Get in touch

What to write about

We welcome:

• Editorial corrections — if you spot a factual error, a misquoted hazard ratio, or a citation that has been superseded by a more recent paper, please tell us.
• Citation requests — if you want the primary source for a claim that you cannot find on the references page.
• Coverage suggestions — if a recent semaglutide trial has been published that we have not yet summarized.
• Press and academic inquiries — for permission to quote or syndicate content.

What we cannot help with

We cannot:

• Provide medical advice. We are not your clinician. We do not know your medical history, your concurrent medications, your laboratory values, or anything else that would be needed to make a clinical recommendation. If you have questions about whether semaglutide is appropriate for you, the answer is to talk with a licensed healthcare provider — ideally one with experience in GLP-1 receptor agonists and the indication relevant to your situation.
• Sell, supply, or refer you to anyone who sells semaglutide. We are not a pharmacy.
• Diagnose or evaluate any medical condition.
• Respond to clinical emergencies. If you are experiencing a medical emergency, call your local emergency number.

Disclaimer

Editorial commentary on published research and FDA-approved prescribing information. Not medical advice. Consult a qualified healthcare provider for any clinical question. MD Semaglutide is not affiliated with any vendor or manufacturer and does not offer clinical services.